Editorial Policy

The Journal of Cancer and Translational Oncology (JCTO) follows a strict, transparent, and ethically grounded editorial policy to ensure the publication of high-quality research in oncology, cancer biology, and translational medicine.

The journal is committed to maintaining academic integrity, editorial independence, and fairness throughout the manuscript evaluation and publication process. All editorial decisions are based solely on scientific merit, originality, methodological rigor, clinical relevance, and clarity of presentation.

Editorial Independence

The editorial board operates independently and is not influenced by external organizations, funding agencies, or institutional interests. Decisions regarding manuscript acceptance or rejection are made strictly on the basis of peer-review evaluation and scholarly merit.

Initial Manuscript Screening

All submitted manuscripts undergo an initial editorial assessment to determine:

  • Relevance to the journal’s scope

  • Scientific originality and significance

  • Methodological quality and completeness

  • Compliance with submission guidelines

Manuscripts that do not meet minimum requirements may be returned to authors without external review.

Evaluation Criteria

Manuscripts considered for peer review are assessed based on:

  • Scientific novelty and contribution to oncology research

  • Strength and validity of experimental or clinical data

  • Quality of methodology and study design

  • Clarity and structure of presentation

  • Ethical compliance in research involving human or animal subjects

  • Relevance to translational cancer medicine

Editorial Decision Process

After peer review, the editorial board may decide to:

  • Accept the manuscript

  • Request minor revisions

  • Request major revisions and resubmission

  • Reject the manuscript

Final publication decisions are made by the editor based on reviewer recommendations and overall manuscript quality.

Confidentiality

All submitted manuscripts are treated as confidential documents. Editors and reviewers must not disclose, share, or use unpublished material for personal, academic, or commercial advantage.

Conflict of Interest

Editors are required to disclose any conflicts of interest and recuse themselves from handling manuscripts where impartiality may be compromised. The journal ensures fair and unbiased editorial handling in all cases.

Ethical Oversight

The journal follows international publication ethics standards and takes allegations of misconduct seriously, including plagiarism, data fabrication, duplicate submission, and unethical research practices. Appropriate corrective actions are taken when necessary.

Commitment to Quality

The Journal of Cancer and Translational Oncology is dedicated to maintaining high editorial standards and ensuring the integrity, credibility, and scientific impact of published research in oncology and translational medicine.